Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2083 of 5804
-
AI may predict ulcerative colitis severity before a scope — a study puts it to the test
Knowledge-focused OngoingThis multicenter retrospective observational study aims to develop and externally validate a machine learning model that predicts Montreal ulcerative colitis (UC) disease extent (E1: limited/proctitis; E2: left-sided; E3: extensive) using pre-endoscopic clinical information, incl…
Sponsor: Beijing University of Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Targeted drug shows promise for rare NF2-Mutated cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of VS-6063 (defactinib) in patients whose cancer has a genetic change called NF2 mutation. Defactinib may block a protein called FAK, which may be needed for cancer cell growth when NF2 mutations are present. Researchers …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New PET scan aims to spot hidden cancers with precision
Diagnosis OngoingThis pilot clinical trial studies copper Cu 64 anti-carcinoembryonic antigen (CEA) monoclonal antibody M5A positron emission tomography (PET) in diagnosing patients with CEA positive cancer. Diagnostic procedures, such as copper Cu 64 anti-CEA monoclonal antibody M5A PET, may hel…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New chemo combo tested for rare gut cancers – results disappoint
Disease control OngoingThis randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that has spread to other part…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
15-Year study tracks hidden risks of CAR-T cancer therapy
Knowledge-focused Recruiting nowPer Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapi…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Robots teach kids with autism to read emotions
Symptom relief CompletedThis study is being done to examine the impact of an interactive, social robotics program in helping children with autism spectrum disorders (ASD) understand emotions and how to better recognize emotions while interacting with others. Eligible families will be randomized to eithe…
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 19:05 UTC
-
Face mask zaps nerve pain: new hope for trigeminal neuralgia?
Symptom relief OngoingTo determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New blood thinner may shield heart during artery procedure
Disease control CompletedRotational atherectomy (RA) prior to angioplasty is the reference treatment for highly calcified atherosclerotic coronary lesions. It aims at fragmenting calcium deposits into microscopic particulates to allow less hazardous coronary revascularization and stenting. The main drawb…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a diabetes shot shield heart and kidneys? new study investigates.
Disease control CompletedAmong adult individuals with type 2 diabetes mellitus and at risk for heart failure with impaired relaxation of the heart mildly reduced kidney filtration function (Type 4 cardiorenal syndrome) this trial will evaluate the quantitative impact of 38 weeks of treatment with exenati…
Phase: PHASE3 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
One extra shot around embryo transfer may lift IVF live birth rates
Disease control Recruiting nowDuring IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to …
Phase: PHASE4 • Sponsor: University Reproductive Associates • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a pill speed up hip fracture recovery in seniors?
Disease control CompletedThis is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to investigate the safety, tolerability, and efficacy of VK5211 after 12 weeks of treatment. Males and females ≥65 years old who are ambulatory and recovering from a hip fracture will be el…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control TerminatedThis phase I trial studies the side effects and best dose of nivolumab when given with ipilimumab in treating patients with human immunodeficiency virus (HIV) associated classical Hodgkin lymphoma that has returned after a period of improvement (relapsed) or does not respond to t…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New scan may improve cancer detection for men with inherited risk
Diagnosis Recruiting nowThe aim of the study is to determine if PET-CT imaging (using contrast recommended in clinical guidelines) is superior to combined bone scan and MRI/CT of the abdomen \& pelvis in detecting the increased incidence of metastasis (nodal/distant outside the pelvis) in men with prost…
Sponsor: Institute of Cancer Research, United Kingdom • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New drug shows promise for heart muscle disease symptoms
Symptom relief CompletedHypertrophic cardiomyopathy (HCM) is the most frequent genetic cardiac disease characterized by an asymmetric hypertrophic. In two third of patients, an obstruction to blood ejection is observed within the left ventricle which is named left ventricular outflow tract obstruction (…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Leukemia treatment showdown: which works best?
Knowledge-focused OngoingThe registry aims to compare the two first-line available treatment approaches in non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO - in terms of practitioner's choice between the two options, clinical effectiveness and cost-effectiveness, long…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Real-World study tests safety of new heart stents
Disease control OngoingThe purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New knee implant could last longer without cement
Disease control OngoingThe optimal method of total knee replacement component fixation to the bone remains a challenge. The use of bone cement is considered the gold standard and is the preferred technique for most surgeons. However, uncemented fixation methods have been developed in an attempt to tack…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
New device may predict kidney recovery in ICU patients
Diagnosis CompletedPatients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI).
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
1,000 patients to be studied for 2 years after bariatric surgery
Knowledge-focused Recruiting nowThe Bialystok Bariatric Surgery Study (BBSS) is a prospective observational cohort study of patients undergoing bariatric surgery at the First Clinical Department of General and Endocrine Surgery at the Medical University of Bialystok. The BBSS consists of a battery of baseline t…
Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could HIV drugs tame a rare immune disease in kids?
Disease control CompletedThe purpose of this study is to determine if treatment with reverse transcriptase inhibitors returns the interferon signature observed in patients with AGS to normal levels.
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC